IP Verse

Compound For Use In The Treatment Of Ocular Disorders - EP3811943

PATENT ANALYSIS

Patent Details

Grant Date
Feb 22, 2023
Company
AERIE PHARMACEUTICALS, INC.
Oppositions

GENERICS (UK) LTD

ISARPATENT - PATENT- UND RECHTSANWALTE BARTH HASSA PECKMANN UND PARTNER MBB

TER MEER STEINMEISTER & PARTNER PATENTANWALTE MBB

More patents of Aerie Pharmaceuticals, Inc.

EP3811943

EP3461484

Want to monitor this patent?

Feel free to send us a message here and we will get back to you